kabutan

TEIJIN LIMITED(3401) Summary

3401
TSE Prime
TEIJIN LIMITED
1,312.0
JPY
+17.5
(+1.35%)
Dec 12, 3:30 pm JST
8.42
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.66
Yield
3.81%
Margin Trading Ratio
8.54
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,311.0 JPY 8.43 USD
Previous Close Dec 11
1,294.5 JPY 8.29 USD
High Dec 12, 9:49 am
1,316.5 JPY 8.45 USD
Low Dec 12, 9:00 am
1,301.0 JPY 8.36 USD
Volume
625,900
Trading Value
0.82B JPY 5.27M USD
VWAP
1310.84 JPY 8.41 USD
Minimum Trading Value
131,200 JPY 842 USD
Market Cap
0.26T JPY 1.68B USD
Number of Trades
1,341
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,765
1-Year High Nov 5, 2025
8,979
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 173,900 2,079,500 11.96
Nov 28, 2025 187,200 2,021,600 10.80
Nov 21, 2025 196,800 2,022,800 10.28
Nov 14, 2025 174,600 2,005,800 11.49
Nov 7, 2025 165,100 1,969,600 11.93
Company Profile
TEIJIN LIMITED is a major synthetic fiber manufacturer, ranking second globally in carbon fiber production. The company's three main pillars are synthetic fibers, chemical products, and pharmaceuticals/medical care. It also has a presence in the healthcare sector.
Sector
Texstiles & Apparels
TEIJIN LIMITED operates in various business segments including materials, fibers & products, healthcare, and IT. In its materials business, the company manufactures and sells high-performance materials such as aramid fibers, resins, and carbon fibers, as well as composite materials. The fibers & products division focuses on the manufacture and sale of fiber products, polyester fibers, and textiles. In healthcare, TEIJIN LIMITED manufactures and sells pharmaceuticals and medical devices, while also providing home healthcare services. The IT business segment offers information system operation, development, and maintenance services, as well as electronic comic distribution. Additionally, the company manufactures and sells battery materials and membranes, and develops, manufactures, and sells regenerative medicine products and implantable medical devices.